Work

Inhibition Of Lyn and Syk By Treatment With Dasatinib, Fludarabine, and Rituximab Correlates With Apoptosis and Clinical Response In Patients With Relapsed CLL

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.5300.5300

Authors: Philip C. Amrein, Xin Kai, Carlos Donato, Jon Arnason, Jennifer R. Brown, Karen K. Ballen, Eyal C. Attar, Amir T. Fathi, Ephraim P Hochberg, HyukJoo Hwang, Lillian Werner, Donna Neuberg, Shiv Pillai

Institutions: Harvard University, Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W35466291

FWCI:

Cites:

Cited by: 1

Related to: 10